Nuvation Bio, Inc.(NUVB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NUVB Nuvation Bio, Inc.

Pre-Mkt 05-13 06:39:46 EDT

4.84

+0.08

+1.68%

盘前4.92

+0.08+1.75%

06:07 EDT

High4.88	Low4.66	Vol2.54M
Open4.75	D1 Closing4.76	Amplitude4.62%
Mkt Cap1.68B	Tradable Cap1.12B	Total Shares347.60M
T/O12.14M	T/O Rate1.10%	Tradable Shares231.05M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NUVB","market":"US","secType":"STK","nameCN":"Nuvation Bio, Inc.","latestPrice":4.84,"timestamp":1778616000000,"preClose":4.76,"halted":0,"volume":2540752,"hourTrading":{"tag":"盘前","latestPrice":4.9249,"preClose":4.84,"latestTime":"06:07 EDT","volume":22,"amount":108.3478,"timestamp":1778666828571,"change":0.0849,"changeRate":0.017541,"amplitude":0},"delay":0,"changeRate":0.016806722689075647,"floatShares":231046340,"shares":347597289,"eps":-0.424745,"marketStatus":"Pre-Mkt","change":0.08,"latestTime":"05-13 06:39:46 EDT","open":4.75,"high":4.88,"low":4.66,"amount":12136354.181856,"amplitude":0.046218,"askPrice":5.36,"askSize":100,"bidPrice":4.36,"bidSize":90,"shortable":3,"etf":0,"ttmEps":-0.424745,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1778679000000},"marketStatusCode":1,"adr":0,"exchange":"NYSE","adjPreClose":4.84,"preHourTrading":{"tag":"盘前","latestPrice":4.9249,"preClose":4.84,"latestTime":"06:07 EDT","volume":22,"amount":108.3478,"timestamp":1778666828571,"change":0.0849,"changeRate":0.017541,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":4.85,"preClose":4.84,"latestTime":"19:55 EDT","volume":9606,"amount":46487.0106,"timestamp":1778630105021,"change":0.01,"changeRate":0.002066,"amplitude":0.008264},"volumeRatio":0.46442266536389787,"impliedVol":1.3468,"impliedVolPercentile":0.628},"requestUrl":"/m/hq/s/NUVB/wiki","defaultTab":"wiki","newsList":[{"id":"2633116138","title":"Nuvation Bio says FDA accepts IBTROZI label update filing for ROS1+ NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2633116138","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633116138?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:07","pubTimestamp":1778069269,"startTime":"0","endTime":"0","summary":"Nuvation Bio disclosed FDA acceptance of supplemental new drug application seeking to update US label for IBTROZI  in advanced ROS1-positive non-small cell lung cancer, with agency target action date set for Jan. 4, 2027.Filing reflects longer follow-up from pivotal TRUST-I, TRUST-II studies, pointing to sustained patient benefit in both previously untreated, previously treated settings without detailing new safety concerns.Updated study results were already presented at AACR 2026.Move follows IBTROZI full US approval in June 2025, supporting longer-duration efficacy claims that could strengthen positioning across lines of therapy.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL7rVF7P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633118009","title":"Nuvation Bio Announces FDA Acceptance of Supplemental New Drug Application for Ibtrozi® (Taletrectinib) With Updated Duration of Response in Advanced Ros1-Positive Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2633118009","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633118009?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:00","pubTimestamp":1778068817,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nTUA745RWQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633001180","title":"Nuvation Bio Inc - FDA Accepts Supplemental Nda for Ibtrozi in Advanced Ros1+ Nsclc; Target Action Date Jan 4, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2633001180","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633001180?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:00","pubTimestamp":1778068817,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nTUA745RWQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633264729","title":"Nuvation Bio participates in Bank of America Securities Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2633264729","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633264729?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:09","pubTimestamp":1778011794,"startTime":"0","endTime":"0","summary":"Nuvation Bio will take part in investor conference fireside chats, starting May 13, 2026 at Bank of America Securities 2026 Healthcare Conference in Las Vegas.New York events scheduled May 19, 2026 at H.C. Wainwright BioConnect conference, May 20, 2026 at RBC Capital Markets Global Healthcare Conference.Virtual appearance set for May 26, 2026 at TD Cowen 7th Annual Oncology Innovation Summit.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL5PSYfF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119179931","title":"Stock Track | Nuvation Bio Soars 5.33% Intraday on Positive Analyst Coverage and Maintained Price Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=1119179931","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119179931?lang=en_us&edition=fundamental","pubTime":"2026-05-05 22:53","pubTimestamp":1777992830,"startTime":"0","endTime":"0","summary":"Shares of Nuvation Bio, Inc. (NUVB) surged 5.33% during Tuesday's intraday trading session, marking a significant upward movement for the healthcare stock.The stock's rise appears to be driven by...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633149912","title":"Analysts Offer Insights on Healthcare Companies: ADC Therapeutics (ADCT), Evolus (EOLS) and Nuvation Bio (NUVB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633149912","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633149912?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:21","pubTimestamp":1777980070,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on ADC Therapeutics (ADCT), Evolus (EOLS) and Nuvation Bio (NUVB). A...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-adc-therapeutics-adct-evolus-eols-and-nuvation-bio-nuvb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-adc-therapeutics-adct-evolus-eols-and-nuvation-bio-nuvb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADCT","XLV","LABU","XBI","BK4080","EOLS","LU0029874061.USD","BK4139","NUVB","BK4007","HCSG","BK4231","BK4588","BK4137","LU0128526141.USD","BK4585","ADC","BK4581","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633919492","title":"Nuvation Bio Price Target Maintained With a $17.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2633919492","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633919492?lang=en_us&edition=fundamental","pubTime":"2026-05-05 18:34","pubTimestamp":1777977240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NUVB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 05, 2026 06:34 ET (10:34 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633969417","title":"Earnings Flash (NUVB) Nuvation Bio Posts Q1 EPS $0.01, vs. FactSet Est of $0.03 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2633969417","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633969417?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:51","pubTimestamp":1777927906,"startTime":"0","endTime":"0","summary":"Earnings Flash (NUVB) Nuvation Bio Posts Q1 EPS $0.01, vs. FactSet Est of $0.03 Loss","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633296999","title":"Nuvation Bio publishes corporate presentation on IBTROZI ROS1 lung cancer drug```","url":"https://stock-news.laohu8.com/highlight/detail?id=2633296999","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633296999?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:43","pubTimestamp":1777927418,"startTime":"0","endTime":"0","summary":"Nuvation Bio highlighted IBTROZI  as its commercial anchor, citing FDA clearance for advanced ROS1+ NSCLC in June 2025.U.S. net product revenue reached USD 24.7 million in 2025, rising to USD 18.5 million in Q1 2026.Launch metrics showed more than 600 new patient starts as of March 31, 2026, with over 50% of Q1 starts in TKI-nave patients.Pipeline focus centered on safusidenib, a brain-penetrant IDH1 inhibitor enrolling in pivotal SIGMA study in IDH1-mutant astrocytoma with high-risk features.Pro forma cash balance was about USD 534 million as of March 31, 2026, framed as sufficient to support path to profitability without additional funding.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvation Bio Inc. published the original conten","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL8dhYhf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633696617","title":"Nuvation Bio Q1 net income turns positive on IBTROZI sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2633696617","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633696617?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:29","pubTimestamp":1777926565,"startTime":"0","endTime":"0","summary":"Nuvation Bio Q1 net income turns positive on IBTROZI salesOverviewU.S. oncology firm's Q1 net product revenue reached $18.5 mln on IBTROZI launch momentumCompany posted net income of $5.4 mln, reversi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL1N41H10Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","NUVB","CRSF","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633965440","title":"Nuvation Bio Q1 EPS $0.01, Inline, Sales $83.228M Beat $62.259M Estimate.","url":"https://stock-news.laohu8.com/highlight/detail?id=2633965440","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633965440?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:13","pubTimestamp":1777925639,"startTime":"0","endTime":"0","summary":"Nuvation Bio (NYSE:NUVB) reported quarterly earnings of $0.01 per share which met the analyst consensus estimate. This is a 106.25 percent increase over losses of $(0.16) per share from the same period last year.  The","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52264925/nuvation-bio-q1-eps-0-01-inline-sales-83-228m-beat-62-259m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Nuvation Bio Q1 EPS $0.01, Inline, Sales $83.228M Beat $62.259M Estimate.","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633638965","title":"BRIEF-Nuvation Bio Q1 EPS USD 0.01","url":"https://stock-news.laohu8.com/highlight/detail?id=2633638965","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633638965?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:10","pubTimestamp":1777925445,"startTime":"0","endTime":"0","summary":"BRIEF-Nuvation Bio Q1 EPS USD 0.01\n\n\nMay 04 (Reuters) - Nuvation Bio Q1 income from pperations USD 3.881 million.\n\nQ1 pretax profit USD 5.397 million\nQ1 net income USD 5.397 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nPLX6D63D8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633656819","title":"Nuvation Bio Q1 Pretax Profit USD 5.397 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633656819","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633656819?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:10","pubTimestamp":1777925401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nPLX6D63D8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633651649","title":"Press Release: Nuvation Bio Reports First Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2633651649","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633651649?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:10","pubTimestamp":1777925400,"startTime":"0","endTime":"0","summary":"Achieved $18.5 million in first quarter of 2026 net product revenues for IBTROZI ; majority of the approximately 200 patients started on IBTROZI in the first quarter of 2026 were TKI-nave, highlighting continued momentum in the first-line setting. Presented newly updated clinical data demonstrating IBTROZI's impressive durability of response and progression-free survival in TKI-nave and TKI-pretreated patients with advanced ROS1-positive  non-small cell lung cancer  at AACR 2026. Announced acquisition of Japan rights to safusidenib from Daiichi Sankyo, enabling global development and commercialization of promising investigational medicine. Strong balance sheet with cash, cash equivalents, and marketable securities of $533.7 million as of March 31, 2026. NEW YORK, May 4, 2026 /PRNewswire/ -- Nuvation Bio Inc. , a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today reported financial results for the first quarter ended March 31, 2026, an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4212","BK4585","R","BK4588","EMA","BK4081","BK4022","CNS","BK4215","NUVB","MAA","BK4007","BK4232","BK4135","DDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630285391","title":"BRIEF-Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib (Ibtrozi®) As Recommended Option","url":"https://stock-news.laohu8.com/highlight/detail?id=2630285391","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630285391?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:50","pubTimestamp":1777294221,"startTime":"0","endTime":"0","summary":"BRIEF-Nuvation Bio Announces National Comprehensive Cancer Network Adds Taletrectinib (Ibtrozi) As Recommended Option April 27 (Reuters) - Nuvation Bio Inc NUVB.N:NUVATION BIO ANNOUNCES NATIONAL COMPR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUAC5KZLN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630965903","title":"Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib (Ibtrozi®) as Recommended Option to Clinical Practice Guidelines in Oncology for Central Nervous System Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2630965903","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630965903?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:00","pubTimestamp":1777291204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUAC5KZLN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193250189","title":"Earning Preview: Nuvation Bio, Inc. Q1 revenue is expected to increase by 14,240.76%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1193250189","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193250189?lang=en_us&edition=fundamental","pubTime":"2026-04-27 13:59","pubTimestamp":1777269594,"startTime":"0","endTime":"0","summary":"Abstract Nuvation Bio, Inc. will release its quarterly results on May 4, 2026 Post Market; this preview outlines expected revenue, profitability metrics, commercial drivers, and how institutional...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Earning Preview: Nuvation Bio, Inc. Q1 revenue is expected to increase by 14,240.76%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629066593","title":"Nuvation Bio reports results from TRUST-I and TRUST-II trials for IBTROZI","url":"https://stock-news.laohu8.com/highlight/detail?id=2629066593","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629066593?lang=en_us&edition=fundamental","pubTime":"2026-04-22 06:05","pubTimestamp":1776809115,"startTime":"0","endTime":"0","summary":"Nuvation Bio (NUVB) announced results from a pooled analysis of long-term follow-up data from the pivotal TRUST-I and TRUST-II trials for IBTROZI, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvation-bio-reports-results-from-trust-i-and-trust-ii-trials-for-ibtrozi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvation-bio-reports-results-from-trust-i-and-trust-ii-trials-for-ibtrozi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629065231","title":"Nuvation Bio publishes corporate presentation on IBTROZI launch, oncology pipeline updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2629065231","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629065231?lang=en_us&edition=fundamental","pubTime":"2026-04-22 06:04","pubTimestamp":1776809083,"startTime":"0","endTime":"0","summary":"Nuvation Bio highlighted IBTROZI  as a commercial-stage growth driver, with U.S. FDA clearance for advanced ROS1+ NSCLC in June 2025.IBTROZI generated USD 24.7 million in U.S. net product revenue in 2025.Pipeline focus centered on safusidenib, an IDH1 inhibitor enrolling in pivotal SIGMA study for high-risk or high-grade IDH1-mutant astrocytoma.Company outlined pro forma cash balance of about USD 589 million, including USD 529.2 million as of Dec. 31, 2025.Presentation also flagged preclinical work from proprietary Drug-Drug Conjugate platform for solid tumors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvation Bio Inc. published the original content used to generate this news brief on April 21, 2026, and is solely responsible for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL21FtpW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629065489","title":"Nuvation Bio says pooled TRUST data show 49.7-month IBTROZI response duration","url":"https://stock-news.laohu8.com/highlight/detail?id=2629065489","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629065489?lang=en_us&edition=fundamental","pubTime":"2026-04-22 06:00","pubTimestamp":1776808850,"startTime":"0","endTime":"0","summary":"Nuvation Bio reported longer-term pooled follow-up from pivotal TRUST-I and TRUST-II studies of IBTROZI  in advanced ROS1-positive NSCLC, with results already presented at AACR 2026.Data showed responses remained durable in patients who had not previously received a ROS1 TKI, supporting IBTROZI’s positioning as a front-line option.Updated analyses also showed continued activity in patients previously treated with earlier ROS1 inhibitors, reinforcing use in later-line settings.Safety remained manageable with no new signals in longer follow-up, supporting sustained treatment use.TRUST-I results were simultaneously published in Journal of Clinical Oncology.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL6YyPGM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":0.0522},{"period":"3month","weight":-0.1538},{"period":"6month","weight":0.032},{"period":"1year","weight":1.2512},{"period":"ytd","weight":-0.4598}],"compareEarnings":[{"period":"1week","weight":0.0199},{"period":"1month","weight":0.0864},{"period":"3month","weight":0.0668},{"period":"6month","weight":0.0984},{"period":"1year","weight":0.2662},{"period":"ytd","weight":0.0825}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung , M.D., who previously founded Medivation, Inc., which brought to patients one of the world's leading prostate cancer medicines. Nuvation Bio has offices in New York and San Francisco .","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.099824},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.044723},{"month":3,"riseRate":0.5,"avgChangeRate":0.083814},{"month":4,"riseRate":0.5,"avgChangeRate":0.010626},{"month":5,"riseRate":0.666667,"avgChangeRate":0.016859},{"month":6,"riseRate":0.2,"avgChangeRate":-0.090917},{"month":7,"riseRate":0.6,"avgChangeRate":0.065913},{"month":8,"riseRate":0.6,"avgChangeRate":0.013694},{"month":9,"riseRate":0.5,"avgChangeRate":-0.038205},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.016548},{"month":11,"riseRate":0.5,"avgChangeRate":0.163132},{"month":12,"riseRate":0.666667,"avgChangeRate":0.061496}],"exchange":"NYSE","name":"Nuvation Bio, Inc.","nameEN":"Nuvation Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nuvation Bio, Inc.(NUVB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Nuvation Bio, Inc.(NUVB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Nuvation Bio, Inc.,NUVB,Nuvation Bio, Inc.股票,Nuvation Bio, Inc.股票老虎,Nuvation Bio, Inc.股票老虎国际,Nuvation Bio, Inc.行情,Nuvation Bio, Inc.股票行情,Nuvation Bio, Inc.股价,Nuvation Bio, Inc.股市,Nuvation Bio, Inc.股票价格,Nuvation Bio, Inc.股票交易,Nuvation Bio, Inc.股票购买,Nuvation Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nuvation Bio, Inc.(NUVB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Nuvation Bio, Inc.(NUVB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction